Implanet plans to acquire a majority stake in Orthopaedic & Spine Development (OSD), developer and manufacturer of implants for spine surgery.
OSD's lineup includes a range of cages, plates and fixation systems for lumbar and cervical applications.
Implanet's offer is valued at €4.2 million (~USD $5.0 million) for 100% of the shares.
Ludovic Lastennet, CEO of Implanet, said “The acquisition of OSD represents a milestone in our strategy, deployed since late 2019, to strengthen Implanet’s position in the orthopedic and spine market. The clinical value of our JAZZ® technology has, over the years, enabled us to become a pivotal player in pediatric spinal deformity, but thus far our range has limited our ability to grow at a similar pace in the degenerative adult segment.
In 2020, Implanet announced its intent to divest knee replacement assets to focus on its spine portfolio.
"This merger with OSD will strengthen our spinal implant range, notably for the adult market, while positioning Implanet as an integrated supplier capable of competing with the market’s largest players. The merger will enable us to rapidly achieve a critical mass in terms of revenue. Reaching this critical mass will ensure that, in the coming years, we will be able to meet regulatory, clinical and economic demands in a fast-growing market."